79243427 - CELLECTIS

Information

  • Trademark
  • 79243427
  • Serial Number
    79243427
  • Registration Number
    6202570
  • Filing Date
    April 06, 2018
    7 years ago
  • Registration Date
    November 24, 2020
    4 years ago
  • Transaction Date
    January 25, 2024
    a year ago
  • Status Date
    November 24, 2020
    4 years ago
  • Published for Opposition Date
    September 08, 2020
    5 years ago
  • Location Date
    November 24, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    COLLOPY, DIANE PATRICI
  • Attorney Docket Number
    SANT0339WOUS
    Attorney Name
    Mary Margaret L. O'Donnell
    Law Office Assigned Location Code
    L70
  • Owners
Mark Drawing Code
3000
Mark Identification
CELLECTIS
Case File Statements
  • DM0000: The mark consists of the literal element "CELLECTIS" wherein the letters "CE ECTIS" are in dark blue and the "L's" are formed in a combination of dark blue, light blue, and medium blue.
  • GS0051: Pharmaceutical products for the treatment of cancer, immune system related diseases and disorders; microorganism cultures and nutritive substances for microorganism cultures for medical and pharmaceutical use; bacteriological preparations for medical and pharmaceutical use; biological preparations for medical and pharmaceutical use for treating cancer, immune system or genetic diseases or disorders, and malnutrition; chemical and biochemical preparations for medical, pharmaceutical, and therapeutic use for treating cancer and malnutrition; micro-organism preparations and cultures for medical, pharmaceutical and veterinary purposes; health food, beverages, preparations and substances, namely, dietetic foods for the treatment of celiac disease, nutritional supplements, medical preparations and substances for treatment of malnutrition, cancer, high cholesterol, cardiovascular disease, diabetes, coronary heart disease, immune system related diseases and disorders, nutritionally fortified beverages for medical purposes; plant-based health-food substances, namely, dietetic foods, namely, edible oils and fats, processed fruits and vegetables, preserved, dried and cooked fruits and vegetables, potato based snack food, soybeans based snack food, potato crisps, potato flakes and potato fritters, potato fries, cooked ready meals consisting primarily of vegetables, soya crisps, soya flakes, soya fries, corn-based snack food, wheat based snack foods, oat based snack foods, alfalfa based snack foods, coffee, coffee substitutes, seasonings, sauces and condiments, namely, mustard, ketchup and other tomatoes sauces, cooked ready meals consisting primarily of pasta or rice, potato, soya, corn, wheat, alfalfa or oat based foods, namely, puree, corn, wheat, alfalfa or oat crisps, soya, corn, wheat, alfalfa and oat flour, corn, wheat, alfalfa and oat flakes, corn, wheat, alfalfa and oat fries, adapted for medical use; dietary supplements; nutritional supplements; nutritional additives in the nature of dietary and nutritional supplements for medical purposes; cultures and preparations of micro-organisms for medical or therapeutic, pharmaceutical and veterinary use, namely, human and animal cells in the nature of biological tissue cultures for the treatment of cancer, immune system related diseases and disorders; bacteriological preparations for in vivo and in vitro genetic engineering, for medical, pharmaceutical and veterinary purposes; medicines for veterinary use for treating cancer and malnutrition; medicines for human use for treating cancer and malnutrition; Diagnostic preparations for the treatment of cancer, immune system related diseases and disorders, malnutrition; Pharmaceutical products for medical purposes in the nature of enzymes, namely, natural and engineered nucleases, nucleic acid vectors, molecular scissors; Chemical and pharmaceutical products for medical purposes in the nature of enzymes, namely, natural and engineered nucleases, nucleic acid vectors and molecular scissors; Veterinary products, namely, nucleic acid sequences being enzymes, stem cells, chemical and biological reagents, bacteria, yeasts, enzymes, bacteriological preparations, natural and engineered endoncucleases being enzymes
  • CC0000: The color(s) dark blue, light blue and medium blue is/are claimed as a feature of the mark.
  • GS0421: Technical studies and evaluation of new products in the pharmaceutical industry; engineering services; computer programming; Design and development of computer software and hardware; scientific and industrial research in the agri-food, horticulture and agriculture sector for genome modification of cells of all types; genetic, medical and pharmaceutical research; research in chemistry, biology, biochemistry, molecular biology or bacteriology; research and development in biochemical analysis, biological analysis and molecular biology techniques; Research and development of new compounds for use in industry, agriculture and horticulture; scientific laboratory services
Case File Event Statements
  • 10/28/2023 - 2 years ago
    50 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 10/18/2023 - 2 years ago
    49 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/18/2023 - 2 years ago
    48 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 10/18/2023 - 2 years ago
    47 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/18/2023 - 2 years ago
    46 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/18/2023 - 2 years ago
    45 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/18/2023 - 2 years ago
    44 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 3/14/2021 - 4 years ago
    43 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 2/24/2021 - 4 years ago
    42 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 2/24/2021 - 4 years ago
    41 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 2/24/2021 - 4 years ago
    40 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 11/24/2020 - 4 years ago
    39 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/8/2020 - 5 years ago
    38 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/8/2020 - 5 years ago
    37 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/5/2020 - 5 years ago
    36 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 8/19/2020 - 5 years ago
    35 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 8/19/2020 - 5 years ago
    34 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 8/19/2020 - 5 years ago
    33 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/3/2020 - 5 years ago
    32 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/3/2020 - 5 years ago
    31 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/3/2020 - 5 years ago
    30 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/27/2020 - 5 years ago
    29 - ASSIGNED TO LIE Type: ALIE
  • 7/24/2020 - 5 years ago
    28 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 4/3/2020 - 5 years ago
    27 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 3/18/2020 - 5 years ago
    26 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 3/18/2020 - 5 years ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 1/31/2020 - 5 years ago
    24 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 1/31/2020 - 5 years ago
    23 - FINAL REFUSAL E-MAILED Type: GNFR
  • 1/31/2020 - 5 years ago
    22 - FINAL REFUSAL WRITTEN Type: CNFR
  • 1/10/2020 - 5 years ago
    21 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 1/10/2020 - 5 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/13/2019 - 5 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/13/2019 - 5 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/11/2019 - 5 years ago
    17 - ASSIGNED TO LIE Type: ALIE
  • 12/2/2019 - 5 years ago
    16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/28/2019 - 6 years ago
    15 - REFUSAL PROCESSED BY IB Type: RFNT
  • 5/30/2019 - 6 years ago
    14 - NON-FINAL ACTION MAILED Type: CNRT
  • 5/29/2019 - 6 years ago
    13 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/8/2019 - 6 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/7/2019 - 6 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/7/2019 - 6 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/8/2018 - 6 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/16/2018 - 6 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 11/15/2018 - 6 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/31/2018 - 7 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/30/2018 - 7 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/27/2018 - 7 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/23/2018 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/23/2018 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/18/2018 - 7 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR